You are wrong.
The US is still the richest country in the world. It is home to nearly all big pharma and major biotech companies.
By contrast Australia generally doesn't take science seriously (I have close friends in other areas of cancer research), and our market doesn't really get biotech.
Remember, there are no more shares being issued here. Everytime a US investor buys a NASDAQ listed ADR 30x PRR get pulled from our market. Increase demand not supply and generally the only question is how much the price will increase...
DNDN may have come back hard, but there are rich people today in America who weren't until they bought it...
a actually dont understand the nasdaq hype, page-2
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |